1. Home >
  2. Johnson & Johnson Acquires Crucell NV

M&A Deal Summary

Johnson & Johnson Acquires Crucell NV

On October 6, 2010, Johnson & Johnson acquired life science company Crucell NV

Acquisition Highlights
  • This is Johnson & Johnson’s 7th transaction in the Life Science sector.
  • This is Johnson & Johnson’s 1st transaction in the Netherlands.

M&A Deal Summary
Date 2010-10-06
Target Crucell NV
Sector Life Science
Buyer(s) Johnson & Johnson
Deal Type Add-on Acquisition

Target

Crucell NV

Leiden, Netherlands
Crucell NV is a global biopharmaceutical company focused on research development, production and marketing of vaccines, proteins and antibodies that prevent and/or treat infectious diseases.

Search 204,883 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Johnson & Johnson

New Brunswick, New Jersey, United States
Category Company
Founded 1886
Sector Consumer Products
Employees132,000
Revenue 85.2B USD (2023)
DESCRIPTION
Johnson & Johnson's corporate headquarters in New Brunswick, New Jersey.
Johnson & Johnson's corporate headquarters in New Brunswick, New Jersey.

Johnson & Johnson is a global healthcare conglomerate that operates across three primary sectors: Pharmaceuticals, Medical Devices, and Consumer Health. In Pharmaceuticals, it develops treatments for a variety of conditions, including immunology, oncology, and infectious diseases. The Medical Devices segment offers a range of equipment and devices for healthcare professionals, encompassing orthopedics, surgery, and cardiovascular care. Its Consumer Health division markets a wide array of products, spanning baby care, oral care, skin care, over-the-counter drugs, and women's health, with popular brands such as Band-Aid, Tylenol, and Neutrogena under its umbrella. Johnson & Johnson was formed in 1886 and is based in New Brunswick, New Jersey.

DEAL STATS #
Overall 23 of 46
Sector (Life Science) 7 of 19
Type (Add-on Acquisition) 18 of 37
Country (Netherlands) 1 of 1
Year (2010) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-09-27 Micrus Endovascular

San Jose, California, United States

Micrus Endovascular is a medical device company formed in June 1996 with its corporate headquarters in San Jose, California. Micrus Endovascular manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Micrus' products are used by interventional neuroradiologists and neurosurgeons primarily to treat cerebral aneurysms in the brain responsible for hemorrhagic stroke, a significant cause of death in the United States. The Micrus product line is an endovascular system that enables a physician to gain access to the brain in a minimally invasive manner through the vessels of the circulatory system.

Buy $480M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-10-09 PURELL

Akron, Ohio, United States

PURELL is an instant hand sanitizer for use in foodservice and healthcare situations when people lack access to soap and water. PURELL was introduced to the consumer market in 1997.

Sell -
Mergr

Product

Company

Legal